Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

• Status: Completed
• Trial end date: 2009-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a 12 week bilateral study, consisting of 6 weeks of treatment and 6 weeks of follow-up. The purpose of the study is to compare the safety and effectiveness of combining and then following a high potency topical corticosteroid treatment with LCD treatment for moderate-to-severe localized plaque psoriasis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: NeoStrata Company, Inc.
• Treatments: Clobetasol

Criteria

Inclusion Criteria:

• 18 years of age or older

• able to provide written informed consent

• able to attend study visits, apply medications, and follow instructions

• moderate to severe localized plaque psoriasis lesions (<10% BSA on each side of the body)

Exclusion Criteria:

• other current treatments for psoriasis

• hypersensitivity to steroids, liquor carbonis detergens, alcohol, fragrance

• pregnant or nursing